136 related articles for article (PubMed ID: 38229430)
1. Tumor-infiltrating T lymphocytes evaluated using digital image analysis predict the prognosis of patients with diffuse large B-cell lymphoma.
Cho Y; Lee J; Han B; Yoon SE; Kim SJ; Kim WS; Cho J
J Pathol Transl Med; 2024 Jan; 58(1):12-21. PubMed ID: 38229430
[TBL] [Abstract][Full Text] [Related]
2. Novel risk stratification of de novo diffuse large B cell lymphoma based on tumour-infiltrating T lymphocytes evaluated by flow cytometry.
Chen Z; Deng X; Ye Y; Gao L; Zhang W; Liu W; Zhao S
Ann Hematol; 2019 Feb; 98(2):391-399. PubMed ID: 30377764
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL.
Xu-Monette ZY; Li Y; Snyder T; Yu T; Lu T; Tzankov A; Visco C; Bhagat G; Qian W; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; Hagemeister FB; Wang Y; Go H; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; Fan X; van Krieken JH; Piris MA; Winter JN; Au Q; Kirsch I; Zhang M; Shaughnessy J; Xu B; Young KH
Clin Cancer Res; 2023 Dec; 29(23):4808-4821. PubMed ID: 37728879
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of the Immunoscore Based on Whole-Slide Image Analysis of CD3+ Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma.
Han B; Yim J; Lim S; Na S; Lee C; Kim TM; Paik JH; Kim S; Jeon YK
Mod Pathol; 2023 Sep; 36(9):100224. PubMed ID: 37257823
[TBL] [Abstract][Full Text] [Related]
5. Flow Cytometry-Assessed PD1/PDL1 Status in Tumor-Infiltrating Lymphocytes: A Link With the Prognosis of Diffuse Large B-Cell Lymphoma.
Chen Z; Deng X; Ye Y; Zhang W; Liu W; Zhao S
Front Oncol; 2021; 11():687911. PubMed ID: 34211855
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma.
Yu T; Xu-Monette ZY; Lagoo A; Shuai W; Wang B; Neff J; Carrillo LF; Carlsen ED; Pina-Oviedo S; Young KH
Front Immunol; 2024; 15():1335689. PubMed ID: 38348048
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study.
Xu Y; Kroft SH; McKenna RW; Aquino DB
Br J Haematol; 2001 Mar; 112(4):945-9. PubMed ID: 11298589
[TBL] [Abstract][Full Text] [Related]
8. Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma.
Pollari M; Pellinen T; Karjalainen-Lindsberg ML; Kellokumpu-Lehtinen PL; Leivonen SK; Leppä S
Eur J Haematol; 2020 Dec; 105(6):712-721. PubMed ID: 32632935
[TBL] [Abstract][Full Text] [Related]
9. Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
Hida AI; Watanabe T; Sagara Y; Kashiwaba M; Sagara Y; Aogi K; Ohi Y; Tanimoto A
Breast Cancer Res Treat; 2019 Nov; 178(2):283-294. PubMed ID: 31402409
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes.
Wang J; Gao K; Lei W; Dong L; Xuan Q; Feng M; Wang J; Ye X; Jin T; Zhang Z; Zhang Q
Oncotarget; 2017 Jan; 8(3):5414-5425. PubMed ID: 28036275
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
[TBL] [Abstract][Full Text] [Related]
12. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of tumor-infiltrating lymphocytes in non-small cell lung cancer patients who received neoadjuvant chemotherapy followed by surgery.
Hou Z; Zhao L; Zou L; Li B
Adv Clin Exp Med; 2023 Aug; 32(8):847-853. PubMed ID: 36881364
[TBL] [Abstract][Full Text] [Related]
14. Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma.
Zhu Q; Deng X; Yao W; Chen Z; Ye Y; Gao L; Zhang W; Liu W; Zhao S
Ann Hematol; 2021 Mar; 100(3):715-723. PubMed ID: 33389024
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8
Xu Y; Liu Z; Lv L; Li P; Xiu B; Qian W; Liang A
J Exp Clin Cancer Res; 2020 Nov; 39(1):238. PubMed ID: 33168024
[TBL] [Abstract][Full Text] [Related]
16. Tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in relation to pathological complete remission to neoadjuvant therapy and prognosis in triple negative breast cancer.
Zhao M; Xing H; He J; Wang X; Liu Y
Pathol Res Pract; 2023 Aug; 248():154687. PubMed ID: 37478522
[TBL] [Abstract][Full Text] [Related]
17. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
18. Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma.
Miyazaki Y; Nawa Y; Miyagawa M; Kohashi S; Nakase K; Yasukawa M; Hara M
Ann Hematol; 2013 Jan; 92(2):239-44. PubMed ID: 23079891
[TBL] [Abstract][Full Text] [Related]
19. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
List AF; Spier CM; Miller TP; Grogan TM
Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
[TBL] [Abstract][Full Text] [Related]
20. Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma.
Shen Y; Wang L; Ou J; Wang B; Cen X
Int J Med Sci; 2022; 19(2):225-232. PubMed ID: 35165508
[No Abstract] [Full Text] [Related]
[Next] [New Search]
